Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| UroGen Pharma Ltd.(URGN) | 2,620,545 | 2,906,259 | +285,714 | $39.31M | $48.77M | 9.34% | +$9.46M |
| Neurogene Inc.(NGNE) | 1,004,291 | 1,004,291 | 0 | $51.12M | $36.55M | 7.00% | -$14.57M |
| ABIVAX Société AnonymeADS(ABVX) | 2,488,483 | 2,472,188 | -16,295 | $35.59M | $32.68M | 6.26% | -$2.90M |
| Merus N V | 223,288 | 523,288 | +300,000 | $10.05M | $30.96M | 5.93% | +$20.91M |
| Pliant Therapeutics, Inc.(PLRX) | 1,851,864 | 2,636,864 | +785,000 | $27.59M | $28.35M | 5.43% | +$753.5K |
| Arcellx Inc COMMON STOCK | 300,000 | 492,000 | +192,000 | $20.86M | $27.15M | 5.20% | +$6.29M |
| Dynavax Technologies Corp | 1,264,920 | 2,374,000 | +1,109,080 | $15.70M | $26.66M | 5.11% | +$10.96M |
| Evolus, Inc.(EOLS) | 2,450,000 | 2,451,772 | +1,772 | $34.30M | $26.60M | 5.10% | -$7.70M |
| Cytokinetics, Incorporated(CYTK) | 202,202 | 474,202 | +272,000 | $14.18M | $25.69M | 4.92% | +$11.52M |
| Dianthus Therapeutics, Inc.(DNTH) | 625,000 | 757,929 | +132,929 | $18.75M | $19.62M | 3.76% | +$865.2K |
| Insmed Incorporated(INSM) | 775,585 | 250,000 | -525,585 | $21.04M | $16.75M | 3.21% | -$4.29M |
| Zura Bio LimitedCL A(ZURA) | 2,757,740 | 4,642,241 | +1,884,501 | $7.09M | $16.25M | 3.11% | +$9.16M |
| Kalvista Pharmaceuticals Inc | 0 | 1,338,568 | +1,338,568 | $0 | $15.77M | 3.02% | +$15.77M |
| Ionis Pharmaceuticals, Inc.(IONS) | 0 | 330,000 | +330,000 | $0 | $15.73M | 3.01% | +$15.73M |
| Context Therapeutics Inc.(CNTX) | 0 | 7,419,355 | +7,419,355 | $0 | $14.88M | 2.85% | +$14.88M |
| Amicus Therapeutics Inc COM | 1,495,500 | 1,495,500 | 0 | $17.62M | $14.84M | 2.84% | -$2.78M |
| Optinose Inc | 8,786,318 | 13,727,097 | +4,940,779 | $12.83M | $14.28M | 2.73% | +$1.45M |
| Esperion Therapeutics Inc Ne | 8,000,000 | 5,791,594 | -2,208,406 | $21.44M | $12.86M | 2.46% | -$8.58M |
| Voyager Therapeutics, Inc.(VYGR) | 0 | 1,601,527 | +1,601,527 | $0 | $12.67M | 2.43% | +$12.67M |
| Outlook Therapeutics, Inc.(OTLK) | 1,480,000 | 1,701,510 | +221,510 | $17.67M | $12.56M | 2.41% | -$5.11M |
| Autolus Therapeutics plcADS(AUTL) | 1,166,667 | 3,441,667 | +2,275,000 | $7.44M | $11.98M | 2.29% | +$4.53M |
| Jasper Therapeutics, Inc.(JSPR) | 407,550 | 402,015 | -5,535 | $11.97M | $9.13M | 1.75% | -$2.84M |
| Olema Pharmaceuticals, Inc.(OLMA) | 0 | 796,880 | +796,880 | $0 | $8.62M | 1.65% | +$8.62M |
| Terns Pharmaceuticals Inc | 1,309,975 | 1,149,406 | -160,569 | $8.59M | $7.83M | 1.50% | -$766.0K |
| Viridian Therapeutics, Inc.(VRDN) | 1,335,000 | 500,000 | -835,000 | $23.38M | $6.50M | 1.25% | -$16.87M |
| TScan Therapeutics, Inc.(TCRX) | 0 | 940,831 | +940,831 | $0 | $5.50M | 1.05% | +$5.50M |
| Vistagen Therapeutics, Inc.(VTGN) | 1,858,735 | 1,529,338 | -329,397 | $9.81M | $5.32M | 1.02% | -$4.49M |
| Helix Acquisition Corp IiCL A | 500,000 | 500,000 | 0 | $5.20M | $5.11M | 0.98% | -$90.0K |
| Puma Biotechnology, Inc.(PBYI) | 1,343,628 | 1,486,544 | +142,916 | $7.12M | $4.85M | 0.93% | -$2.28M |
| Kyverna Therapeutics, Inc.(KYTX) | 150,000 | 499,152 | +349,152 | $3.73M | $3.74M | 0.72% | +$17.6K |
| Spyre Therapeutics, Inc.(SYRE) | 125,000 | 134,612 | +9,612 | $4.74M | $3.16M | 0.61% | -$1.58M |
| Anaptysbio Inc | 976,981 | 25,000 | -951,981 | $22.00M | $626.5K | 0.12% | -$21.38M |
| Lexicon Pharmaceuticals, Inc.(LXRX) | 0 | 30,000 | +30,000 | $0 | $50.4K | 0.01% | +$50.4K |
| Aerovate Therapeutics Inc | 887,690 | 0 | -887,690 | $26.25M | $0 | — | -$26.25M |
| Alpine Immune Sciences Inc | 1,128,499 | 0 | -1,128,499 | $44.73M | $0 | — | -$44.73M |
| Apogee Therapeutics Inc | 400,000 | 0 | -400,000 | $26.58M | $0 | — | -$26.58M |
| Arvinas, Inc.(ARVN) | 71,113 | 0 | -71,113 | $2.94M | $0 | — | -$2.94M |
| Immunocore Holdings plcADS(IMCR) | 115,000 | 0 | -115,000 | $7.47M | $0 | — | -$7.47M |
| Intra-Cellular Therapies Inc | 150,000 | 0 | -150,000 | $10.38M | $0 | — | -$10.38M |
| Mind Medicine Mindmed Inc | 2,000,000 | 0 | -2,000,000 | $18.80M | $0 | — | -$18.80M |
| Ocular Therapeutix, Inc.(OCUL) | 1,728,723 | 0 | -1,728,723 | $15.73M | $0 | — | -$15.73M |
| Xenon Pharmaceuticals Inc.(XENE) | 456,148 | 0 | -456,148 | $19.64M | $0 | — | -$19.64M |